EFSD/Lilly Research Fellowship Programme


Amin Ardestani: University of Bremen - Germany
Targeting hippo effector YAP for beta cell protection in diabetes

Daniele Barbato: University of Rome Tor Vergata - Italy
ProBATion: Mapping nanovesicles-vehicled Proteins released from Brown Adipose Tissue

Rongrong Fan: Karolinska Institute - Stockholm, Sweden
Encrypting the role of macrophage GPS2 in the development of T2D complications

Marta Guasch-Ferré: Pere Virgili Health Research Institute - Reus, Spain
Mechanisms underlying metabolomic profiles and type 2 diabetes

Ka-Cheuk Liu: Karolinska Institute – Stockholm, Sweden
Screen for enhancers of beta cell neogenesis – and follow up on a role for cdk5

Annika Mehlem: Karolinska Institute - Stockholm, Sweden
Inhibition of vascular endothelial growth factor B (VEGF-B), keeping lipids where they belong?

Teresa Mezza: Catholic University of the Sacred Heart - Rome, Italy
Investigating the role of intra-islet GLP-1 production in the modulation of islet plasticity in humans

Ivana Nikolić: Spanish National Center for Cardiovascular Research - Madrid, Spain
Adipose p38delta in control of body metabolism


Maria Rosaria Ambrosio: University of Naples "Federico II" - Italy
Identification of novel glucose-regulated communication signals involved in breast cancer chemoresistance

Jesus Blanco: IDIBAPS - Barcelona, Spain
Mechanisms underlying the formation of beta cell autoantigen-specific regulatory networks in vivo

Jorge Correira: Karolinska Institute - Stockholm, Sweden
Role of Zfp697 in inflammation and metabolic disease

Rodolphe Dusaulcy: University of Geneva Medical School - Switzerland
Role of micro RNAs in pancreatic alpha cells function during type 2 diabetes

Gian Paolo Fadini: Venetian Institute of Molecular Medicine - Padua, Italy
How diabetes affects neutrophil pro-angiogenic phenotype, senescence and NETosis in mice and humans

Kathrin Gaens: Maastricht University - The Netherlands
Obesity-associated hypoxia is a key player in AGE formation and development of type 2 diabetes mellitus

Nikhil Gandasi: Uppsala University - Sweden
Rate limiting factors for sustained insulin secretion from human pancreatic beta cells

Nordin Hassen: Maastricht University - The Netherlands
Are plasma dicarbonyl levels associated with incident cardiovascular disease in type 1 and type 2 diabetes?

Aurora Mazzeo: University of Turin - Italy
Role(s) of circulating extracellular vesicles in pathogenesis and repair of diabetic complications


Caroline Arous: University of Geneva - Switzerland
Adhesions-mediated control of insulin secretion in beta cells

Elise Dalmas: University of Basel - Switzerland
IL-33-induced type 2 immunity in pancreatic islets: role in physiology and diabetes

Sonia Fernández-Veledo: Pere Virgil Health Research Institute - Tarragona, Spain
Central effects of GLP-2R activation: insights into a potential brain-gut-adipose tissue cross-talk

Luca Parrillo: Federico II University of Naples - Italy
Identification of epigenetic signatures underlying increased risk of type 2 diabetes

Xavier Prieur: University of Nantes - France
Deciphering seipin function in the mature adipocyte

Kim Ravnskjaer: University of Southern Denmark - Odense M, Denmark
In situ analysis of hepatic stellate cell signalling in the development of hepatic fibrosis

Mark Russell: University of Exeter - UK
Subcellular localisation of cell cycle regulatory proteins in human beta cells: is the current paradigm correct?

Nicolas Venteclef: Cordeliers Research Centre - Paris France
Characterisation of the immuno-metabolic roles of Interferon regulatory factor 5 in type 2 diabetes


Céline Cruciani-Guglielmacci: Paris Diderot University - France
Does triglyceride lipase activity in hypothalamus control blood glucose homeostasis?

Isabel Göhring: Charité University Medicine Berlin - Germany
Novel regulars of glucose sensing and insulin secretion in pancreatic beta cells 

Veronica Jimènez: Autonomous University of Barcelona - Spain
Therapeutic approaches against type 2 diabetes and obesity targeting adipose tissue with factors that increase energy expenditure

Troy Merry: ETH Zurich - Schwerzenbach, Switzerland
The role of nuclear factor (erythroid-derived 2)-like 2 in exercise-induced metabolic adaptions

Jonas T Treebak: University of Copenhagen - Denmark
Role of NAD-salvage systems for mitochondrial function and insulin sensitivity: implications for type 2 diabetes


Paloma Alonso-Magdalena: Miguel Hernandez University - Elche, Spain
Exposure to endocrine disruptor chemicals during pregnancy: a possible mechanism involved in the premature ageing of maternal pancreatic beta cells

Jordi Altirriba: University of Geneva - Switzerland
Oxytocin effects on adipose tissue inflammation and its impact on insulin resistance 

Yvonne Böttcher: University of Leipzig - Germany
Promotor methylation of glucose transporter 4 (GLUT4) in human subcutaneous and visceral adipose tissue 

Josep Mercador: Technical University of Catalonia - Barcelona, Spain
Systems biology genome-wide association studies to identify novel type 2 diabetes molecular mechanisms 

Emma Nilsson: Lund University - Malmö, Sweden
The role of microRNAs in the development of insulin resistance and type 2 diabetes 

Francesco Ortega: Biomedical Research Institute of Girona - Spain
Circulating microRNAs in pre-pubertal children as biomarkers of metabolic diseases such as type 2 diabetes 

Janna van Diepen: Radboud University - Nijmegen, The Netherlands
Macrophage activation in patients with diabetes: increasing the risk for atherosclerosis 


Lisa Berglund: Lund University - Malmö, Sweden
Role of the incretin hormone GIP in the development of diabetic vascular complications - good or bad?

Maarten Brom: Radboud University - Nijmegen, The Netherlands
Determination of the beta cell mass by SPECT with ¹¹¹ In-exendin in a rat model for type 2 diabetes

Paul Caton: Queen Mary University - London, UK
The role of nicotinamide adenine dinucleotide synthesis in mediating islet-compensation to insulin resistance

Marc Claret: IDIBAPS - Barcelona, Spain
Mitochondrial fusion protein Mitofusin 1 in POMC neurons: potential regulator of energy homeostasis

Jonathan Esguerra: Lund University - Malmö, Sweden
Characterisation of non-coding RNAs in pancreatic islets and microRNAs as blood-based biomarkers in diabetes

Bruno Guigas: Leiden University Medical Center - The Netherlands
Protective effects of parasite-derived molecules in metabolic disorders

Laura Herrero: University of Barcelona - Spain
Enhancing brown adipose tissue fat-burning power as a therapy against obesity-induced diabetes

Shahram Hedjazifar: Lundberg Laboratory for Diabetes Research - Göteborg, Sweden
The role of WISP2, a Wnt-related molecule, in recruitment and differentiation of brown adipocytes - a thereupeutic approach for obesity and type 2 diabetes

Philippe Klee: University Hospital of Geneva – Switzerland
Identification of the molecular mechanisms involved in beta cell protection by cholinergic agonists

Anna Motterle: University of Lausanne – Switzerland
Contribution of long non-coding RNAs in the development of type 2 diabetes

Joris Robben: Radboud University – Nijmegen, The Netherlands
Involvement of the succinate receptor SUCNRI in diabetes-associated damage of kidney, liver and eye

Tamás Röszer: Spanish National Cardiovascular Research Centre - Madrid, Spain
Macrophage specific targeting of retinoid x receptors: role in type 2 diabetes


Romain Barrés: University of Copenhagen - Denmark
The role of transient DNA hypomethylation on muscular adaptation

Federica Barutta: University of Turin - Italy
AM6545 and AM1241 in the prevention/treatment of experimental diabetic nephropathy

Vladimer Darsalia: Karolinska Institute - Stockholm, Sweden
VPAC2 receptor activation for the treatment of stroke in diabetes

Lorenzo Pasquali: IDIBAPS - Barcelona, Spain
Mapping the human pancreatic islet-cell cis regulome

Matthew Simmonds: University of Oxford - UK
Identifying the genetic predictors of graft function in whole organ pancreas transplantation

Tom Van Belle: Ghent University - Belgium
How does 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) act on immune cells during autoimmunity?

Nicholas Venteclef: Pierre and Marie Curie University - Paris, France
Cathepsin S as modulator of glucose homeostasis: depicting its molecular actions in hepatocytes


Stefan  Amisten: University of Oxford - UK
Quantification of all G-protein coupled receptors in human pancreatic islets, alpha- and beta cells

Christian  Andersson:  Sahlgrenska University - Gothenburg, Sweden
Regulation of IL-6 signalling and the inflammation response

Céline  Cruciani-Guglielmacci:  University Paris Diderot - France
Involvement of triglycerides and lipoproteins hydrolysis in rat hippocampus in the control of energy balance

Heidi  de Wet:  University of Oxford - UK
An investigation of the sulfonylurea sensitivity of KATP channels carrying mutations causing neonatal diabetes

Victorine Douin:  Rangueil Hospital, -Toulouse, France
Role of intestinal dendritic cells in the onset of high-fat diet-induced inflammation and type 2 diabetes

Gianpaolo Fadini: University of Padova - Italy
Clinical data-driven research of new stem cell-mobilising agents for vascular repair in diabetes 

Melis Karaca:  University of Geneva - Switzerland
Genetic abrogation of the amplifying pathway in pancreatic beta cells: effects on diet-incuded obesity 

Eckhard  Lammert:  Heinrich-Heine University - Düsseldorf, Germany
Investigation of the role of DJ-1 in glucose tolerance and glucose stimulated insulin secretion from pancreatic islets

Joan-Marc  Servitja: IDIBAPS -Barcelona, Spain
Epigenetic control of gene expression in pancreatic islets

Barbara Ukropcova:  Slovak Academy of Sciences -Bratislava, Slovakia
Metabolic health and muscle secretory profile in aerobic and resistance trained obese pre-diabetic individuals


Marie Björnholm: Karolinska Institutet - Stockholm, Sweden
Leptin receptor signalling - integration of central and peripheral effects

Ann  Hammarstedt -  The Lundberg Laboratory - Gothenburg, Sweden
WISP-2 - a novel adipokine related to obesity and insulin resistance

Paolo  Rossetti: University of Perugia - Italy
Restoration of glucagon response to insulin induced hypoglycaemia in type 1 diabetes mellitus subjects: the role of the amino acids

Giovanni  Solinas:  University of Fribourg - Germany
Investigating the role of phosphoinositide-3 kinase γ in diet-induced obesity and insulin resistance


Ferdinando Giacco: Federico II University - Italy
Effect of "metabolic memory" and ROS production on bone marrow endothelial progenitor (EPCs) function

Lina Lauffer: University of Toronto -Canada
The role of GPR119 and OEA in the regulation of GLP-1 secretion


Aouatef Ait-Lounis: University of Geneva - Switzerland
Role of the transcription factor RFX3 and cilia in the function of beta cells

Justo Sierra Johnson: Karolinska University Hospital - Sweden
Effects of physical activity on the metabolic syndrome and gene expression in adipose tissue


Karim Bouzakri: Geneva University - Switzerland
Synergistic signalling by hormones and ECM acting on beta-cell function, replication and survival

Sarah Longnus: Nice University Hospital - France 
AMPK, a potential therapeutic target for improving myocardial glucose use in diabetes?